The influence of age on transfer factor treatment of cellular immunodeficiency, chronic fatigue syndrome and/or chronic viral infections

Biotherapy

Volumn 9, Issue 1-3, 1996, Pages 91-95

  Harm, Ivo ^a   Vrubel, Jiri ^a   Pekarek, Jan ^b   Cech, Karel ^a  

^a INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^b Institute of Sera and Vaccines   (Czech Republic)

Author keywords

age; cell mediated immunity; chronic fatigue syndrome; immunodeficiency; immunomodulation; transfer factor

Indexed keywords

IMMUNE TRANSFER FACTOR; IMMUNOGLOBULIN G; TRANSFER FACTOR; VITAMIN;

ADOLESCENT; ADULT; AGE; AGED; CELLULAR IMMUNODEFICIENCY; CHRONIC FATIGUE SYNDROME; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOMEGALOVIRUS; DISEASE COURSE; EPSTEIN BARR VIRUS; FEMALE; GENDER; HUMAN; IMMUNE FUNCTION TEST; INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STATISTICAL ANALYSIS; SUBCUTANEOUS DRUG ADMINISTRATION; T LYMPHOCYTE; TREATMENT FAILURE; VIRUS INFECTION;

EID: 0029756827     PISSN: 0921299X     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf02628664     Document Type: Conference Paper

References (18)

1. Aiuti F, Businco L, Fiorilli M, Galli E, Quinti I,Rossi P, Semira R & Goldstein G. Thymopoietin pentapeptide treatment of primary immunodeficiencies. Lancet 1983; 1: 551-554.
2. Weksler M, Innés J & Goldstein G. Immunological studies of aging. The contribution of thymic involution to the immune deficiency of aging mice and reversal with thymopoietin. J Exp Med 1978; 1948: 996-1006.
3. Meroni P, Barcellini W, Frasca D, Sguotti C, Borgi MO De Bartolo G, Doria G & Zanussi C. In vivo immune-potentiating activity of thymopoietin in aging humans: increase of IL-2 production. Clin Imm Im 1987; 42: 151-159.
4. Frasca D, Adorini L, Mandai C & Doria G. Reconstruction of T- cell function in aging mice by thymosin alpha one. Immunophatm 1986; 11:155-163.
5. Wara D, Goldstein A & Doyle N. Thymosin activity in patients with cellular immunodeficiency. New Eng J Med 1975; 292: 70-74.
6. DePaoli P, Battistin S & Santini G. Age-related changes in human lymphocyte subsets: progressive reduction of the CD4 CD45R (supressor inducer) population, din Immun Im 1988; 48:290-296.
7. Weksler M: Senescence of the immune system. Med Clin NA 1983; 67: 263-272.
8. Murasko D, Nelson B, Silver R, Matour D & Daye D. Immunologie response in an elderly population with a mean age of 85. Am J Med 1986; 81:612-618.
9. Powers D, Nagel J, Höh J, Adler W. Immune function in the elderly. PostgrMed 1987; 81: 355-359.
10. Amadori A, Zanovello P, Cozzi E, Ciminale V, Borghesan F, Fagiolo U & Crepaldi G. Study of some early immunological parameters in aging humans. Gerontology 1988; 34: 277-283.
11. Grossman J, Baum J & Gluckman J. The effect of aging and acute illness on delayed hypersensitivity. J Allerg Cl 1975; 55: 268-275.
12. Fukuda K, Straus SE, Hiclde I, Sharpe MC, Dobbins JG & Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study. Ann Intern Med 1994; 121:953-959.
13. Holmes GP: Defining the chronic fatigue syndrome. Rev Infect Dis 1991; 13, Suppl. 1: S53-55.
14. Gottlieb AA, Garmer JL, Benes E, Montgomery A, Del Signore C, Smith R, Bertucci D & Sinha S. Augmentation of antigen-induced interleukin-2 receptor expression and gamma-interferon production by IMREG-1, a leukocyte derived immunomodulator. In: Pruzanski W, Seligmann M, eds. Clinical Immunology. Amsterdam: Elsevier Scientific Publishers BV 1987: 357-60.
15. Vranova Z, Vrubel J. Vysetrovani imunitniho stavu nemocnych pred srdecni operaci pomoci soupravy Imunoskintest Sevac. Rozhl Chir 1989; 68: 631-636.
16. Pekarek J.: Lecebne vyuziti pripravku Inunodin Sevac (Transfer faktor) u nekterych poruch bunecne imunity. Zpravy Sevac 1992; 1:4-18.
17. Hana I, Stara J, Boguszakova J, Dostal C, Pekarek J. Immunological studies of recurrent anterior uveitis and therapeutic attempts with transfer factor. In: Ferraz de Olivier LN, ed. Ophthalmology Today. Amsterdam: Elsevier Scientific Publishers BV, 1988:421-423.
18. Straus SE, Dale JK, Tobi M, Lawley T, Preble O, Blaese RM, Hallahan C & Henle W. Acyclovir treatment of the chronic fatigue syndrome. Lack of efficacy in a placebo-controlled trial. New Eng J Med 1988; 319: 1692-98.